- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 413/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 413/00
Total number of patents in this class: 343
10-year publication summary
|
18
|
7
|
4
|
4
|
13
|
9
|
5
|
5
|
5
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4880 |
15 |
| Merck Sharp & Dohme LLC | 3751 |
15 |
| Boehringer Ingelheim International GmbH | 4642 |
11 |
| Merck Sharp & Dohme Corp. | 2191 |
10 |
| Janssen Pharmaceutica N.V. | 3394 |
10 |
| Merck Patent GmbH | 5815 |
8 |
| Novartis AG | 10744 |
6 |
| Glaxosmithkline LLC | 537 |
6 |
| Amgen Inc. | 4076 |
6 |
| Gilead Sciences, Inc. | 2032 |
5 |
| Intellikine LLC | 42 |
4 |
| Hoffmann-La Roche Inc. | 3439 |
3 |
| Syngenta Participations AG | 1904 |
3 |
| Allergan, Inc. | 2347 |
3 |
| Merck Sharp & Dohme B.V. | 708 |
3 |
| Takeda Pharmaceutical Company Limited | 2708 |
3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 703 |
3 |
| Rigel Pharmaceuticals, Inc. | 538 |
3 |
| Eisai R&D Management Co., Ltd. | 1232 |
3 |
| in The Bowl Animal Health, Inc. | 34 |
3 |
| Other owners | 220 |